These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 17474063

  • 1. Possible application of human c-Ha-ras proto-oncogene transgenic rats in a medium-term bioassay model for carcinogens.
    Ohnishi T, Fukamachi K, Ohshima Y, Jiegou X, Ueda S, Iigo M, Takasuka N, Naito A, Fujita K, Matsuoka Y, Izumi K, Tsuda H.
    Toxicol Pathol; 2007 Apr; 35(3):436-43. PubMed ID: 17474063
    [Abstract] [Full Text] [Related]

  • 2. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
    Ota T, Asamoto M, Toriyama-Baba H, Yamamoto F, Matsuoka Y, Ochiya T, Sekiya T, Terada M, Akaza H, Tsuda H.
    Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
    [Abstract] [Full Text] [Related]

  • 3. Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis.
    Asamoto M, Ochiya T, Toriyama-Baba H, Ota T, Sekiya T, Terada M, Tsuda H.
    Carcinogenesis; 2000 Feb; 21(2):243-9. PubMed ID: 10657964
    [Abstract] [Full Text] [Related]

  • 4. Gpx2 is an overexpressed gene in rat breast cancers induced by three different chemical carcinogens.
    Naiki-Ito A, Asamoto M, Hokaiwado N, Takahashi S, Yamashita H, Tsuda H, Ogawa K, Shirai T.
    Cancer Res; 2007 Dec 01; 67(23):11353-8. PubMed ID: 18056462
    [Abstract] [Full Text] [Related]

  • 5. High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis.
    Tsuda H, Asamoto M, Ochiya T, Toriyama-Baba H, Naito A, Ota T, Sekiya T, Terada M.
    Mutat Res; 2001 Jun 02; 477(1-2):173-82. PubMed ID: 11376698
    [Abstract] [Full Text] [Related]

  • 6. Rapid induction of skin and mammary tumors in human c-Ha-ras proto-oncogene transgenic rats by treatment with 7,12-dimethylbenz[a]anthracene followed by 12-O-tetradecanoylphorbol 13-acetate.
    Park CB, Fukamachi K, Takasuka N, Han BS, Kim CK, Hamaguchi T, Fujita K, Ueda S, Tsuda H.
    Cancer Sci; 2004 Mar 02; 95(3):205-10. PubMed ID: 15016318
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of tongue carcinogenesis in Hras128 transgenic rats treated with 4-nitroquinoline 1-oxide.
    Naoi K, Sunagawa N, Yoshida I, Morioka T, Nakashima M, Ishihara M, Fukamachi K, Itoh Y, Tsuda H, Yoshimi N, Suzui M.
    Oncol Rep; 2010 Feb 02; 23(2):337-44. PubMed ID: 20043093
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Transgenic rats carrying human c-Ha-ras proto-oncogene are highly susceptible to N-nitrosomethylbenzylamine induction of esophageal tumorigenesis.
    Asamoto M, Toriyama-Baba H, Ohnishi T, Naito A, Ota T, Ando A, Ochiya T, Tsuda H.
    Jpn J Cancer Res; 2002 Jul 02; 93(7):744-51. PubMed ID: 12149139
    [Abstract] [Full Text] [Related]

  • 10. Decreased susceptibility to NMU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the rat Harvey ras promoter.
    Thompson TA, Haag JD, Lindstrom MJ, Griep AE, Lohse JK, Gould MN.
    Oncogene; 2002 Apr 25; 21(18):2797-804. PubMed ID: 11973638
    [Abstract] [Full Text] [Related]

  • 11. Prevention by antioxidants of heterocyclic amine-induced carcinogenesis in a rat medium-term liver bioassay: results of extended and combination treatment experiments.
    Hirose M, Futakuchi M, Tanaka H, Orita SI, Ito T, Miki T, Shirai T.
    Eur J Cancer Prev; 1998 Feb 25; 7(1):61-7. PubMed ID: 9511852
    [Abstract] [Full Text] [Related]

  • 12. Terminal endbuds and acini as the respective major targets for chemical and sporadic carcinogenesis in the mammary glands of human c-Ha-ras protooncogene transgenic rats.
    Hamaguchi T, Matsuoka Y, Kawaguchi H, Fukamachi K, Takasuka N, Ueda S, Shimizu K, Ohki M, Kusunoki M, Sakakura T, Yoshida H, Tsuda H.
    Breast Cancer Res Treat; 2004 Jan 25; 83(1):43-56. PubMed ID: 14997054
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Preferential mammary carcinogenic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in human c-Ha-ras proto-oncogene transgenic rats.
    Naito A, Suzuki A, Ueda S, Nomoto H, Toriyama-Baba H, Asamoto M, Tsuda H.
    Cancer Sci; 2004 May 25; 95(5):399-403. PubMed ID: 15132766
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effects of 17beta-estradiol and 4-n-octylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats.
    Han BS, Fukamachi K, Takasuka N, Ohnishi T, Maeda M, Yamasaki T, Tsuda H.
    Carcinogenesis; 2002 Jul 25; 23(7):1209-15. PubMed ID: 12117780
    [Abstract] [Full Text] [Related]

  • 17. Multigenerational reproductive study of genistein (Cas No. 446-72-0) in Sprague-Dawley rats (feed study).
    National Toxicology Program.
    Natl Toxicol Program Tech Rep Ser; 2008 Mar 25; (539):1-266. PubMed ID: 18685713
    [Abstract] [Full Text] [Related]

  • 18. Lack of promoting effect of titanium dioxide particles on ultraviolet B-initiated skin carcinogenesis in rats.
    Xu J, Sagawa Y, Futakuchi M, Fukamachi K, Alexander DB, Furukawa F, Ikarashi Y, Uchino T, Nishimura T, Morita A, Suzui M, Tsuda H.
    Food Chem Toxicol; 2011 Jun 25; 49(6):1298-302. PubMed ID: 21414375
    [Abstract] [Full Text] [Related]

  • 19. Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors.
    Wu Y, Cui K, Miyoshi K, Hennighausen L, Green JE, Setser J, LeRoith D, Yakar S.
    Cancer Res; 2003 Aug 01; 63(15):4384-8. PubMed ID: 12907608
    [Abstract] [Full Text] [Related]

  • 20. Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer.
    Singh J, Hamid R, Reddy BS.
    Cancer Res; 1997 Jan 15; 57(2):253-8. PubMed ID: 9000564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.